Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Howell

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
The International Journal on Drug Policy|March 29, 2022
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020Anna Lee Wilkinson, Daniela K van Santen, Michael W Traeger, et al.
Internal Medicine Journal|March 5, 2026
Accelerated impact of alcohol-associated hepatitis on healthcare utilisation during the COVID-19 pandemicLeya Nedumannil, Steven Cheema, Simon J Hume, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2023
Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
The Medical Journal of Australia|August 7, 2024
Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for actionJessica Howell, Troy Combo, Paula Binks, et al.
Journal of Hepatology|September 29, 2016
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinomaDavid J Pinato, Rohini Sharma, Elias Allara, et al.
Journal of Hepatology|September 24, 2020
A global investment framework for the elimination of hepatitis BJessica Howell, Alisa Pedrana, Sophia E Schroeder, et al.
Journal of Hepatology|September 5, 2020
Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with ageJessica Howell, David Anderson, Stephen Bloom, et al.
The Lancet. Gastroenterology & Hepatology|July 31, 2020
Global hepatitis C elimination: an investment frameworkAlisa Pedrana, Jessica Howell, Nick Scott, et al.
The International Journal on Drug Policy|January 28, 2024
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facilityMichael B MacIsaac, Bradley Whitton, Jenine Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2024
Long-Term Outcomes of a Decentralized, Nurse-Led, Statewide Model of Care for Hepatitis C Among People in Prison in Victoria, AustraliaMichael B MacIsaac, Timothy Papaluca, Lucy McDonald, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
The International Journal on Drug Policy|March 29, 2022
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020Anna Lee Wilkinson, Daniela K van Santen, Michael W Traeger, et al.
Internal Medicine Journal|March 5, 2026
Accelerated impact of alcohol-associated hepatitis on healthcare utilisation during the COVID-19 pandemicLeya Nedumannil, Steven Cheema, Simon J Hume, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2023
Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
The Medical Journal of Australia|August 7, 2024
Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for actionJessica Howell, Troy Combo, Paula Binks, et al.
Journal of Hepatology|September 29, 2016
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinomaDavid J Pinato, Rohini Sharma, Elias Allara, et al.
Journal of Hepatology|September 24, 2020
A global investment framework for the elimination of hepatitis BJessica Howell, Alisa Pedrana, Sophia E Schroeder, et al.
Journal of Hepatology|September 5, 2020
Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with ageJessica Howell, David Anderson, Stephen Bloom, et al.
The Lancet. Gastroenterology & Hepatology|July 31, 2020
Global hepatitis C elimination: an investment frameworkAlisa Pedrana, Jessica Howell, Nick Scott, et al.
The International Journal on Drug Policy|January 28, 2024
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facilityMichael B MacIsaac, Bradley Whitton, Jenine Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2024
Long-Term Outcomes of a Decentralized, Nurse-Led, Statewide Model of Care for Hepatitis C Among People in Prison in Victoria, AustraliaMichael B MacIsaac, Timothy Papaluca, Lucy McDonald, et al.
Pageof 10